ABT
Price
$114.23
Change
+$1.81 (+1.61%)
Updated
Dec 20 closing price
32 days until earnings call
BSX
Price
$88.99
Change
+$0.33 (+0.37%)
Updated
Dec 20, 04:59 PM (EDT)
39 days until earnings call
Ad is loading...

ABT vs BSX

Header iconABT vs BSX Comparison
Open Charts ABT vs BSXBanner chart's image
Abbott Laboratories
Price$114.23
Change+$1.81 (+1.61%)
Volume$12.31M
CapitalizationN/A
Boston Scientific
Price$88.99
Change+$0.33 (+0.37%)
Volume$70.31K
CapitalizationN/A
ABT vs BSX Comparison Chart
Loading...
ABT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
BSX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ABT vs. BSX commentary
Dec 22, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ABT is a Hold and BSX is a Hold.

COMPARISON
Comparison
Dec 22, 2024
Stock price -- (ABT: $114.23 vs. BSX: $88.95)
Brand notoriety: ABT and BSX are both notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: ABT: 222% vs. BSX: 257%
Market capitalization -- ABT: $194.5B vs. BSX: $100.1B
ABT [@Medical Specialties] is valued at $194.5B. BSX’s [@Medical Specialties] market capitalization is $100.1B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.04B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ABT’s FA Score shows that 1 FA rating(s) are green whileBSX’s FA Score has 2 green FA rating(s).

  • ABT’s FA Score: 1 green, 4 red.
  • BSX’s FA Score: 2 green, 3 red.
According to our system of comparison, BSX is a better buy in the long-term than ABT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ABT’s TA Score shows that 3 TA indicator(s) are bullish while BSX’s TA Score has 5 bullish TA indicator(s).

  • ABT’s TA Score: 3 bullish, 6 bearish.
  • BSX’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, BSX is a better buy in the short-term than ABT.

Price Growth

ABT (@Medical Specialties) experienced а +0.75% price change this week, while BSX (@Medical Specialties) price change was -1.29% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -1.51%. For the same industry, the average monthly price growth was +1.92%, and the average quarterly price growth was +0.64%.

Reported Earning Dates

ABT is expected to report earnings on Jan 22, 2025.

BSX is expected to report earnings on Jan 29, 2025.

Industries' Descriptions

@Medical Specialties (-1.51% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ABT($194B) has a higher market cap than BSX($100B). BSX has higher P/E ratio than ABT: BSX (63.64) vs ABT (34.38). BSX YTD gains are higher at: 53.866 vs. ABT (5.850). ABT has higher annual earnings (EBITDA): 10.5B vs. BSX (3.45B). ABT has more cash in the bank: 7.28B vs. BSX (865M). BSX has less debt than ABT: BSX (9.49B) vs ABT (15.6B). ABT has higher revenues than BSX: ABT (40.1B) vs BSX (14.2B).
ABTBSXABT / BSX
Capitalization194B100B194%
EBITDA10.5B3.45B305%
Gain YTD5.85053.86611%
P/E Ratio34.3863.6454%
Revenue40.1B14.2B282%
Total Cash7.28B865M842%
Total Debt15.6B9.49B164%
FUNDAMENTALS RATINGS
ABT vs BSX: Fundamental Ratings
ABT
BSX
OUTLOOK RATING
1..100
6474
VALUATION
overvalued / fair valued / undervalued
1..100
10
Undervalued
80
Overvalued
PROFIT vs RISK RATING
1..100
4010
SMR RATING
1..100
5672
PRICE GROWTH RATING
1..100
5343
P/E GROWTH RATING
1..100
5330
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ABT's Valuation (10) in the Medical Specialties industry is significantly better than the same rating for BSX (80). This means that ABT’s stock grew significantly faster than BSX’s over the last 12 months.

BSX's Profit vs Risk Rating (10) in the Medical Specialties industry is in the same range as ABT (40). This means that BSX’s stock grew similarly to ABT’s over the last 12 months.

ABT's SMR Rating (56) in the Medical Specialties industry is in the same range as BSX (72). This means that ABT’s stock grew similarly to BSX’s over the last 12 months.

BSX's Price Growth Rating (43) in the Medical Specialties industry is in the same range as ABT (53). This means that BSX’s stock grew similarly to ABT’s over the last 12 months.

BSX's P/E Growth Rating (30) in the Medical Specialties industry is in the same range as ABT (53). This means that BSX’s stock grew similarly to ABT’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ABTBSX
RSI
ODDS (%)
Bullish Trend 2 days ago
54%
Bearish Trend 2 days ago
41%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
55%
Bullish Trend 2 days ago
63%
Momentum
ODDS (%)
Bearish Trend 2 days ago
51%
Bearish Trend 2 days ago
57%
MACD
ODDS (%)
Bearish Trend 2 days ago
46%
Bearish Trend 2 days ago
55%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
57%
Bearish Trend 2 days ago
47%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
51%
Bearish Trend 2 days ago
50%
Advances
ODDS (%)
Bullish Trend 2 days ago
58%
Bullish Trend 2 days ago
61%
Declines
ODDS (%)
Bearish Trend 6 days ago
52%
Bearish Trend 4 days ago
48%
BollingerBands
ODDS (%)
N/A
Bullish Trend 2 days ago
81%
Aroon
ODDS (%)
Bearish Trend 2 days ago
48%
Bullish Trend 2 days ago
62%
View a ticker or compare two or three
Ad is loading...
ABT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
BSX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
DOCS57.832.65
+4.80%
Doximity
INBK37.380.60
+1.63%
First Internet Bancorp
LEXX2.230.02
+0.90%
Lexaria Bioscience Corp
MSCI604.804.22
+0.70%
MSCI
JKS23.80-0.22
-0.92%
Jinkosolar Holdings CO

BSX and

Correlation & Price change

A.I.dvisor indicates that over the last year, BSX has been loosely correlated with SYK. These tickers have moved in lockstep 58% of the time. This A.I.-generated data suggests there is some statistical probability that if BSX jumps, then SYK could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BSX
1D Price
Change %
BSX100%
+0.33%
SYK - BSX
58%
Loosely correlated
+2.09%
ISRG - BSX
52%
Loosely correlated
+0.10%
RVTY - BSX
52%
Loosely correlated
+1.83%
EW - BSX
44%
Loosely correlated
+1.19%
ITGR - BSX
35%
Loosely correlated
+0.59%
More